Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Feb;16(2):41-6.
doi: 10.1007/BF03086116.

Left ventricular assist device: a functional comparison with heart transplantation

Affiliations

Left ventricular assist device: a functional comparison with heart transplantation

R V Pruijsten et al. Neth Heart J. 2008 Feb.

Abstract

Background: A growing number of patients with end-stage heart failure undergo implantation of ventricular assist devices as a bridge to heart transplantation.

Objectives: In this study we investigated whether functional and haemodynamic recovery after implantation is sufficient to warrant the use of them as long-term alternative to heart transplantation.

Methods: We compared peak VO(2) of a group of patients three months after implantation of a ventricular assist device and three months after heart transplantation. Furthermore, we analysed the degree of haemodynamic recovery, by comparing plasma levels of BNP and creatinine before and after implantation of the device.

Results: After implantation of a ventricular assist device, exercise capacity improved considerably; three months after implantation peak VO(2) was 20.0+/-4.9 ml/kg/min (52% of predicted for age and gender). After heart transplantation exercise capacity improved even further; 24.0+/-3.9 ml/ kg/min (62% of predicted for age and gender) (p<0.001). In the three months after implantation, BNP plasma levels decreased from 570+/-307 pmol/l to 31+/-25 pmol/l and creatinine levels decreased from 191+/-82 mumol/l to 82+/-25 mumol/l, indicating significant unloading of the ventricles and haemodynamic recovery.

Conclusion: With regard to functional and haemodynamic recovery, the effect of implantation of a ventricular assist device is sufficient to justify its use as an alternative to heart transplantation. (Neth Heart J 2008;16:41-6.).

Keywords: heart failure; heart transplantation; ventricular assist device.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The HeartMate XVE left ventricular assist device (LVAD). The inflow cannula is implanted in the left ventricular apex, the outflow graft is connected to the ascending aorta
Figure 2
Figure 2
Mean plasma BNP levels, before and after ventricular assist device implantation.
Figure 3
Figure 3
Mean serum creatinine levels, before and after ventricular assist device implantation.

References

    1. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-8. - PubMed
    1. Jaski BE, Lingle RJ, Kim J, Branch KR, Goldsmith R, Johnson MR, et al. Comparison of functional capacity in patients with endstage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial. J Heart Lung Transplant 1999;18:1031-40. - PubMed
    1. Chatterjee K. Refractory heart failure - drugs and devices. Eur Heart J 2001;22:2227-30. - PubMed
    1. Oosterom A, de Jonge N, Kirkels JH, Rodermans BF, Sukkel E, Klöpping C, et al. End-stage heart failure and mechanical circulatory support: feasibility of discharge from hospital. Neth Heart J 2007;15:45-50. - PMC - PubMed
    1. Lahpor JR, de Jonge N, van Swieten HA, Wesenhagen H, Klöpping C, Geertman JH, et al. Left ventricular assist device as bridge to transplantation in patients with end-stage heart failure. Neth Heart J 2002;10:267-71. - PMC - PubMed

LinkOut - more resources